Article Details
Retrieved on: 2021-01-05 14:25:45
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Symvivo Corporation, a clinical-stage biotechnology company advancing a proprietary bacTRL™ gene delivery platform, announced today that it has ...
Article found on: www.valdostadailytimes.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here